RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-κB-dependent MMP-2 and bcl-2 pathway

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 12, 2013, Pages 1669-1680

  Yang, X C ^a   Wang, Xinsheng ^a   Luo, L ^a   Dong, D H ^a   Yu, Q C ^a   Wang, X S ^a   Zhao, K ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Bcl 2; MMP 2; NF B; Renal cancer; S100A4

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BATIMASTAT; BIOLOGICAL MARKER; CALVASCULIN; COMPLEMENTARY DNA; FLUORESCEIN ISOTHIOCYANATE; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BCL 2; SMALL INTERFERING RNA; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CELL GROWTH; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; METASTASIS INHIBITION; MICROVASCULATURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, MESSENGER; S100 PROTEINS;

EID: 84884257477     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. GARRETT SC, VARNEY KM, WEBER DJ, BRESNICK AR. S100A4, a mediator of metastasis. J Biol Chem 2006; 281: 677-680.
2. MALASHKEVICH VN, VARNEY KM, GARRETT SC, WILDER PT, KNIGHT D, CHARPENTIER TH, RAMAGOPAL UA, ALMO SC, WEBER DJ, BRESNICK AR. Structure of Ca2+- bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA. Biochemistry 2008; 47: 5111-5126.
3. SCHMIDT-HANSEN B, ORNAS D, GRIGORIAN M, KLINGELHOFER J, TULCHINSKY E, LUKANIDIN E, AMBARTSUMIAN N. Extracellular S100A4 (mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004; 23: 5487-5495.
4. BELOT N, POCHET R, HEIZMANN CW, KISS R, DECAESTECKER C. Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. Biochim Biophys Acta 2002; 1600: 74-83.
5. SEMOV A, MORENO MJ, ONICHTCHENKO A, ABULROB A, BALL M, EKIEL I, PIETRZYNSKI G, STANIMIROVIC D, ALAKHOV V. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005; 280: 20833-20841.
6. SCHMIDT-HANSEN B, KLINGELHOFER J, GRUM-SCHWENSEN B, CHRISTENSEN A, ANDRESEN S, KRUSE C, HANSEN T, AMBARTSUMIAN N, LUKANIDIN E, GRIGORIAN M. Functional significance of metastasis-inducing S100A4 (Mts1) in tumor-stroma interplay. J Biol Chem 2004; 279: 24498-24504.
7. YAMMANI RR, CARLSON CS, BRESNICK AR, LOESER RF. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 2006; 54: 2901-2911.
8. XIE R, SCHLUMBRECHT MP, SHIPLEY GL, XIE S, BASSETT RL JR, BROADDUS RR. S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling. Lab Invest 2009; 89: 937-947.
9. ZHANG HY, ZHENG XZ, WANG XH, XUAN XY, WANG F, LI SS. S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity. Mol Biol Rep 2012; 39: 199-208.
10. GROTTERØD I, MAELANDSMO GM, BOYE K. SIGNAL transduction mechanisms involved in S100A4-induced activation of the transcription factor NFkappaB. BMC Cancer 2010; 10: 241.
11. BANDIERA A, MELLONI G, FRESCHI M, GIOVANARDI M, CARRETTA A, BORRI A, CIRIACO P, ZANNINI P. Prognostic factors and analysis of S100A4 protein in resected pulmonary metastases from renal cell carcinoma. World J Surg 2009; 33: 1414-1420.
12. METEOGLU I, ERDOGDU IH, MEYDAN N, ERKUS M, BARUTCA S. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues. J Exp Clin Cancer Res 2008; 27: 53.
13. SOURBIER C, DANILIN S, LINDNER V, STEGER J, ROTHHUT S, MEYER N, JACQMIN D, HELWIG JJ, LANG H, MASSFELDER T. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy. Cancer Res 2007; 67: 11668-11676.
14. OYA M, TAKAYANAGI A, HORIGUCHI A, MIZUNO R, OHTSUBO M, MARUMO K, SHIMIZU N, MURAI M. Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 2003; 24: 377-384.
15. JIAO X, LIU X, ZHANG B, WANG J, WANG Q, TAO Y, ZHANG D. Knockdown of snail sensitizes pancreatic cancer cells to chemotherapeutic agents and irradiation. Int J Mol Sci 2010; 11: 4891-4892.
16. WAN F, LENARDO MJ. The nuclear signaling of NFkappaB: current knowledge, new insights, and future perspectives. Cell Res 2010; 20: 24-33.
17. OYA M, TAKAYANAGI A, HORIGUCHI A, MIZUNO R, OHTSUBO M, MARUMO K, SHIMIZU N, MURAI M. Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 2003; 24: 377-384.
18. SOURBIER C, DANILIN S, LINDNER V, STEGER J, ROTHHUT S, MEYER N, JACQMIN D, HELWIG JJ, LANG H, MASSFELDER T. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy. Cancer Res 2007; 67: 11668-11676.
19. MORAIS C, HEALY H, JOHNSON DW, GOBE G. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma. Nephrol Dial Transplant 2010; 25: 1462-1474.
20. SOURBIER C, DANILIN S, LINDNER V. Targeting the nuclear factor-kb rescue pathway has promising future in human renal cell carcinoma therapy. Cancer Res 2007; 67: 11668-11676.
21. KIKUCHI N, HORIUCHI A, OSADA R, IMAI T, WANG C, CHEN X, KONISHI I. Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/ paracrine factor in tumor progression. Cancer Sci 2006; 97: 1061-1069.
22. SCHMIDT-HANSEN B, KLINGELHOFER J, GRUM-SCHWENSEN B, CHRISTENSEN A, ANDRESEN S, KRUSE C, HANSEN T, AMBARTSUMIAN N, LUKANIDIN E, GRIGORIAN M. Functional significance of metastasis-inducing S100A4 (Mts1) intumor-stroma interplay. J Biol Chem 2004; 279: 24498-24504.
23. YAMMANI RR, CARLSON CS, BRESNICK AR, LOESER RF. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 2006; 54: 2901-2911.
24. SCHMIDT-HANSEN B, ORNAS D, GRIGORIAN M, KLINGELHOFER J, TULCHINSKY E, LUKANIDIN E, AMBARTSUMIAN N. Extracellular S100A4 (mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004; 23: 5487-5495.
25. BJØRNLAND K, WINBERG JO, ODEGAARD OT, HOVIG E, LOENNECHEN T, AASEN AO, FODSTAD O, MAELANDSMO GM. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999; 59: 4702-4708.
26. SEMOV A, MORENO MJ, ONICHTCHENKO A, ABULROB A, BALL M, EKIEL I, PIETRZYNSKI G, STANIMIROVIC D, ALAKHOV V. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005; 280: 20833-20841.